ProfoundBio, led by Seagen veterans, raises $70M ProfoundBio has raised $70 million to advance two of its oncology drug candidates into clinical trial. The company is developing… Read More
ProfoundBio, led by Seagen veterans and co-located in China and Seattle, raises $55M ProfoundBio, based in Woodinville, Wash., and Suzhou, China, has raised $55 million in a Series A funding round to advance… Read More
